86 related articles for article (PubMed ID: 9004452)
1. Biotransformation and detoxification of insecticidal metyrapone analogues by carbonyl reduction in the human liver.
Rekka EA; Soldan M; Belai I; Netter KJ; Maser E
Xenobiotica; 1996 Dec; 26(12):1221-9. PubMed ID: 9004452
[TBL] [Abstract][Full Text] [Related]
2. 11beta-Hydroxysteroid dehydrogenase type 1: tissue-specific expression and reductive metabolism of some anti-insect agent azole analogues of metyrapone.
Bannenberg G; Martin HJ; Bélai I; Maser E
Chem Biol Interact; 2003 Feb; 143-144():449-57. PubMed ID: 12604231
[TBL] [Abstract][Full Text] [Related]
3. 11 beta-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds.
Maser E; Bannenberg G
Biochem Pharmacol; 1994 May; 47(10):1805-12. PubMed ID: 8204097
[TBL] [Abstract][Full Text] [Related]
4. In vitro characterization of the enzymes involved in the metabolism of 1-furan-2-yl-3-pyridin-2-yl-propenone, an anti-inflammatory propenone compound.
Lee SK; Kim JH; Seo YM; Kim HC; Kang MJ; Jeong HG; Lee ES; Jeong TC
Arch Pharm Res; 2008 Jun; 31(6):764-70. PubMed ID: 18563359
[TBL] [Abstract][Full Text] [Related]
5. High carbonyl reductase activity in adrenal gland and ovary emphasizes its role in carbonyl compound detoxication.
Maser E; Hoffmann JG; Friebertshäuser J; Netter KJ
Toxicology; 1992 Aug; 74(1):45-56. PubMed ID: 1514187
[TBL] [Abstract][Full Text] [Related]
6. Carbonyl reduction of bupropion in human liver.
Molnari JC; Myers AL
Xenobiotica; 2012 Jun; 42(6):550-61. PubMed ID: 22339467
[TBL] [Abstract][Full Text] [Related]
7. Reductive metabolism of metyrapone by a quercitrin-sensitive ketone reductase in mouse liver cytosol.
Maser E; Netter KJ
Biochem Pharmacol; 1991 Jun; 41(11):1595-9. PubMed ID: 2043149
[TBL] [Abstract][Full Text] [Related]
8. Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung.
Maser E; Stinner B; Atalla A
Cancer Lett; 2000 Feb; 148(2):135-44. PubMed ID: 10695989
[TBL] [Abstract][Full Text] [Related]
9. Oral pharmacokinetics and in-vitro metabolism of metyrapone in male rats.
Murata H; Higuchi T; Otagiri M
J Pharm Pharmacol; 2016 Aug; 68(8):970-9. PubMed ID: 27265478
[TBL] [Abstract][Full Text] [Related]
10. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
Lin DX; Lang NP; Kadlubar FF
Drug Metab Dispos; 1995 Apr; 23(4):518-24. PubMed ID: 7600922
[TBL] [Abstract][Full Text] [Related]
11. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
Wang YP; Yan J; Fu PP; Chou MW
Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
[TBL] [Abstract][Full Text] [Related]
12. Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes.
Maser E; Oppermann UC
Eur J Biochem; 1997 Oct; 249(2):365-9. PubMed ID: 9370342
[TBL] [Abstract][Full Text] [Related]
13. 17 beta-Estradiol metabolism by hamster hepatic microsomes. Implications for the catechol-O-methyl transferase-mediated detoxication of catechol estrogens.
Butterworth M; Lau SS; Monks TJ
Drug Metab Dispos; 1996 May; 24(5):588-94. PubMed ID: 8723741
[TBL] [Abstract][Full Text] [Related]
14. Metyrapone reductase purified partially from liver microsomes of male rats: the enzyme differs from acetohexamide reductase.
Imamura Y; Murata H; Otagiri M
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):219-26. PubMed ID: 9226756
[TBL] [Abstract][Full Text] [Related]
15. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
Deo AK; Bandiera SM
Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
[TBL] [Abstract][Full Text] [Related]
16. In vitro biotransformation of finasteride in rat hepatic microsomes. Isolation and characterization of metabolites.
Ishii Y; Mukoyama H; Ohtawa M
Drug Metab Dispos; 1994; 22(1):79-84. PubMed ID: 8149894
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
Ling KH; Leeson GA; Burmaster SD; Hook RH; Reith MK; Cheng LK
Drug Metab Dispos; 1995 Jun; 23(6):631-6. PubMed ID: 7587944
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the potential anticancer drug oracin in the rat liver in-vitro.
Szotáková B; Skálová L; Wsól V; Kvasniècková E
J Pharm Pharmacol; 2000 May; 52(5):495-500. PubMed ID: 10864136
[TBL] [Abstract][Full Text] [Related]
19. Carbonyl reduction of metyrapone in human liver.
Maser E; Gebel T; Netter KJ
Biochem Pharmacol; 1991 Dec; 42 Suppl():S93-8. PubMed ID: 1722672
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
Vyas KP; Kari PH; Prakash SR; Duggan DE
Drug Metab Dispos; 1990; 18(2):218-22. PubMed ID: 1971576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
